Released on = December 11, 2006, 10:39 am

Press Release Author = hayley

Industry = Healthcare

Press Release Summary = Clinical study in Europe, the USA and Canada promisingly
http://acomplia.orgfree.com/acomplia_approval_canada.html

Press Release Body = Acomplia - a medicament affects the well-being feeling center
Sanofi Aventis itself at present in far advanced evaluation, in clinical phase so
mentioned III medicine present Acomplia (active substance Rimonabant) could affect
our craze behavior - meal, nicotine and possibly also alcohol - in revolutionary way
positively.

Acomplia works as an antagonist so mentioned at the well-being feeling center in the
brain, i.e. it blocks the receptors, without activating her thereby and thus their
function to release in this case well-being feeling coupled with appetite.

If one takes thus this medicine, the satisfying effect, but thus also releasing
appetite does not adjust themselves after further food or nicotine, with following
food intake or also when smoking.

Clinical study in Europe, the USA and Canada promisingly
For more: http://acomplia.orgfree.com/

Web Site = http://acomplia.orgfree.com/

Contact Details = http://acomplia.orgfree.com/sitemap.html